{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:17:31Z","timestamp":1767143851055,"version":"build-2238731810"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"GlaxoSmithKline Biologicals SA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s40264-021-01141-4","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T03:02:30Z","timestamp":1641870150000},"page":"155-168","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3930-7320","authenticated-orcid":false,"given":"Tina","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1247-2163","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9rique","family":"Delannois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4989-3738","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Haguinet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifeter Yenwo","family":"Molo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"issue":"5","key":"1141_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3201\/eid0905.020562","volume":"9","author":"UD Parashar","year":"2003","unstructured":"Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003;9(5):565\u201372. https:\/\/doi.org\/10.3201\/eid0905.020562.","journal-title":"Emerg Infect Dis"},{"key":"1141_CR2","first-page":"525","volume":"76","author":"NA Cunliffe","year":"1998","unstructured":"Cunliffe NA, Kilgore PE, Bresee JS, Steele AD, Luo N, Hart CA, et al. Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization. Bull World Health Organ. 1998;76:525\u201337.","journal-title":"Bull World Health Organ"},{"issue":"6","key":"1141_CR3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1590\/s1020-49892004001200002","volume":"16","author":"EM Kane","year":"2004","unstructured":"Kane EM, Turcios RM, Arvay ML, Garcia S, Bresee JS, Glass RI. The epidemiology of rotavirus diarrhea in Latin America. Anticipating rotavirus vaccines. Rev Panam Salud Publ. 2004;16(6):371\u20137. https:\/\/doi.org\/10.1590\/s1020-49892004001200002.","journal-title":"Rev Panam Salud Publ"},{"issue":"11","key":"1141_CR4","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/infdis\/jix186","volume":"215","author":"E Burnett","year":"2017","unstructured":"Burnett E, Jonesteller CL, Tate JE, Yen C, Parashar UD. Global impact of rotavirus vaccination on childhood hospitalizations and mortality from diarrhea. J Infect Dis. 2017;215(11):1666\u201372. https:\/\/doi.org\/10.1093\/infdis\/jix186.","journal-title":"J Infect Dis"},{"issue":"7","key":"1141_CR5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1080\/08035250213227","volume":"91","author":"B Ehlken","year":"2002","unstructured":"Ehlken B, Laubereau B, Karmaus W, Petersen G, Rohwedder A, Forster J. Prospective population-based study on rotavirus disease in Germany. Acta Paediatr. 2002;91(7):769\u201375. https:\/\/doi.org\/10.1080\/08035250213227.","journal-title":"Acta Paediatr"},{"issue":"426","key":"1141_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1651-2227.1999.tb14329.x","volume":"88","author":"FM Ruggeri","year":"1999","unstructured":"Ruggeri FM, Declich S. Rotavirus infection among children with diarrhoea in Italy. Acta Paediatr Suppl. 1999;88(426):66\u201371. https:\/\/doi.org\/10.1111\/j.1651-2227.1999.tb14329.x.","journal-title":"Acta Paediatr Suppl"},{"key":"1141_CR7","unstructured":"Rotavirus vaccines. WHO position paper\u2014January 2013. Wkly Epidemiol Rec. 2013;88:49-64"},{"issue":"Suppl 2","key":"1141_CR8","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1093\/cid\/civ1013","volume":"62","author":"JE Tate","year":"2016","unstructured":"Tate JE, Burton AH, Boschi-Pinto C, Parashar UD. Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000\u20132013. Clin Infect Dis. 2016;62(Suppl 2):S96\u2013105. https:\/\/doi.org\/10.1093\/cid\/civ1013.","journal-title":"Clin Infect Dis"},{"key":"1141_CR9","unstructured":"Bines JE, Ivanoff B. Acute intusussception in infants and children. Incidence, clinical presentation and management: a global perspective. 2002. http:\/\/apps.who.int\/iris\/bitstream\/10665\/67720\/1\/WHO_V-B_02.19_eng.pdf. Accessed 29 Nov 2021."},{"issue":"8","key":"1141_CR10","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1097\/01.inf.0000078374.82903.e8","volume":"22","author":"M O'Ryan","year":"2003","unstructured":"O\u2019Ryan M, Lucero Y, Pena A, Valenzuela MT. Two year review of intestinal intussusception in six large public hospitals of Santiago, Chile. Pediatr Infect Dis J. 2003;22(8):717\u201321. https:\/\/doi.org\/10.1097\/01.inf.0000078374.82903.e8.","journal-title":"Pediatr Infect Dis J"},{"key":"1141_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000055064.76457.f3","author":"I Perez-Schael","year":"2003","unstructured":"Perez-Schael I, Escalona M, Salinas B, Materan M, Perez ME, Gonzalez G. Intussusception-associated hospitalization among Venezuelan infants during 1998 through 2001: anticipating rotavirus vaccines. Pediatr Infect Dis J. 2003. https:\/\/doi.org\/10.1097\/01.inf.0000055064.76457.f3.","journal-title":"Pediatr Infect Dis J"},{"key":"1141_CR12","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1593429","author":"P Marsicovetere","year":"2017","unstructured":"Marsicovetere P, Ivatury SJ, White B, Holubar SD. Intestinal intussusception: etiology, diagnosis, and treatment. Clin Colon Rectal Surg. 2017. https:\/\/doi.org\/10.1055\/s-0036-1593429.","journal-title":"Clin Colon Rectal Surg"},{"key":"1141_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz621","author":"E Burnett","year":"2020","unstructured":"Burnett E, Kabir F, Van Trang N, Rayamajhi A, Satter SM, Liu J, et al. Infectious etiologies of intussusception among children <\u00a02\u00a0years old in 4 Asian Countries. J Infect Dis. 2020. https:\/\/doi.org\/10.1093\/infdis\/jiz621.","journal-title":"J Infect Dis"},{"key":"1141_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.154.3.250","author":"N Kuppermann","year":"2000","unstructured":"Kuppermann N, O\u2019Dea T, Pinckney L, Hoecker C. Predictors of intussusception in young children. Arch Pediatr Adolesc Med. 2000. https:\/\/doi.org\/10.1001\/archpedi.154.3.250.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"1141_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000197713.32880.46","author":"HI Huppertz","year":"2006","unstructured":"Huppertz HI, Soriano-Gabarro M, Grimprel E, Franco E, Mezner Z, Desselberger U, et al. Intussusception among young children in Europe. Pediatr Infect Dis J. 2006. https:\/\/doi.org\/10.1097\/01.inf.0000197713.32880.46.","journal-title":"Pediatr Infect Dis J"},{"key":"1141_CR16","doi-asserted-by":"publisher","DOI":"10.1542\/peds.110.6.e67","author":"G Peter","year":"2002","unstructured":"Peter G, Myers MG. Intussusception, rotavirus, and oral vaccines: summary of a workshop. Pediatrics. 2002. https:\/\/doi.org\/10.1542\/peds.110.6.e67.","journal-title":"Pediatrics"},{"key":"1141_CR17","unstructured":"WHO Prequalified Vaccines. WHO. https:\/\/extranet.who.int\/gavi\/PQ_Web\/Default.aspx?nav=1. Accessed 23 Jul 2020."},{"key":"1141_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008521.pub6","author":"H Bergman","year":"2021","unstructured":"Bergman H, Henschke N, Hungerford D, Pitan F, Ndwandwe D, Cunliffe N, et al. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev. 2021. https:\/\/doi.org\/10.1002\/14651858.CD008521.pub6.","journal-title":"Cochrane Database Syst Rev"},{"key":"1141_CR19","unstructured":"Rotarix Summary of Product Characteristics. 2020. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/rotarix-epar-product-information_en.pdf. Accessed 29 Nov 2021."},{"key":"1141_CR20","unstructured":"International Vaccine Access Center (IVAC). Johns Hopkins Bloomberg School of Public Health. https:\/\/view-hub.org\/. Accessed 23 July 2020."},{"key":"1141_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318253add3","author":"FR Velazquez","year":"2012","unstructured":"Velazquez FR, Colindres RE, Grajales C, Hernandez MT, Mercadillo MG, Torres FJ, et al. Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico. Pediatr Infect Dis J. 2012. https:\/\/doi.org\/10.1097\/INF.0b013e318253add3.","journal-title":"Pediatr Infect Dis J"},{"key":"1141_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2003.09.016","author":"JE Bines","year":"2004","unstructured":"Bines JE, Kohl KS, Forster J, Zanardi LR, Davis RL, Hansen J, et al. Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine. 2004. https:\/\/doi.org\/10.1016\/j.vaccine.2003.09.016.","journal-title":"Vaccine"},{"key":"1141_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.01.088","author":"JP Buttery","year":"2011","unstructured":"Buttery JP, Danchin MH, Lee KJ, Carlin JB, McIntyre PB, Elliott EJ, et al. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine. 2011. https:\/\/doi.org\/10.1016\/j.vaccine.2011.01.088.","journal-title":"Vaccine"},{"key":"1141_CR24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713909","author":"JE Tate","year":"2018","unstructured":"Tate JE, Mwenda JM, Armah G, Jani B, Omore R, Ademe A, et al. Evaluation of intussusception after monovalent rotavirus vaccination in Africa. N Engl J Med. 2018. https:\/\/doi.org\/10.1056\/NEJMoa1713909.","journal-title":"N Engl J Med"},{"key":"1141_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/inf.0000000000000715","author":"D Rosillon","year":"2015","unstructured":"Rosillon D, Buyse H, Friedland LR, Ng SP, Velazquez FR, Breuer T. Risk of intussusception after rotavirus vaccination: meta-analysis of postlicensure studies. Pediatr Infect Dis J. 2015. https:\/\/doi.org\/10.1097\/inf.0000000000000715.","journal-title":"Pediatr Infect Dis J"},{"key":"1141_CR26","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-2554","author":"P Haber","year":"2013","unstructured":"Haber P, Patel M, Pan Y, Baggs J, Haber M, Museru O, et al. Intussusception after rotavirus vaccines reported to US VAERS, 2006\u20132012. Pediatrics. 2013. https:\/\/doi.org\/10.1542\/peds.2012-2554.","journal-title":"Pediatrics"},{"key":"1141_CR27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1012952","author":"MM Patel","year":"2011","unstructured":"Patel MM, L\u00f3pez-Collada VR, Bulh\u00f5es MM, De Oliveira LH, Bautista M\u00e1rquez A, Flannery B, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med. 2011. https:\/\/doi.org\/10.1056\/NEJMoa1012952.","journal-title":"N Engl J Med"},{"key":"1141_CR28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1303164","author":"WK Yih","year":"2014","unstructured":"Yih WK, Lieu TA, Kulldorff M, Martin D, McMahill-Walraven CN, Platt R, et al. Intussusception risk after rotavirus vaccination in US infants. N Engl J Med. 2014. https:\/\/doi.org\/10.1056\/NEJMoa1303164.","journal-title":"N Engl J Med"},{"key":"1141_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit520","author":"JB Carlin","year":"2013","unstructured":"Carlin JB, Macartney KK, Lee KJ, Quinn HE, Buttery J, Lopert R, et al. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia\u2019s National Immunization Program. Clin Infect Dis. 2013. https:\/\/doi.org\/10.1093\/cid\/cit520.","journal-title":"Clin Infect Dis"},{"key":"1141_CR30","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1240846","author":"S Hawken","year":"2017","unstructured":"Hawken S, Ducharme R, Rosella LC, Benchimol EI, Langley JM, Wilson K, et al. Assessing the risk of intussusception and rotavirus vaccine safety in Canada. Hum Vaccin Immunother. 2017. https:\/\/doi.org\/10.1080\/21645515.2016.1240846.","journal-title":"Hum Vaccin Immunother"},{"key":"1141_CR31","doi-asserted-by":"publisher","DOI":"10.14776\/piv.2016.23.3.202","author":"H Nam","year":"2016","unstructured":"Nam H, Lim KI, Tchah H, Ryoo E, Sun Y, Cho H. Occurrence pattern of intussusception according to the introduction of rotavirus vaccine: an observational study at a university hospital. Pediatr Infect Vaccine. 2016. https:\/\/doi.org\/10.14776\/piv.2016.23.3.202.","journal-title":"Pediatr Infect Vaccine"},{"key":"1141_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001644","author":"C Yen","year":"2017","unstructured":"Yen C, Shih S-M, Tate JE, Wu F-T, Huang Y-C, Parashar UD, et al. Intussusception-related hospitalizations among infants before and after private market licensure of rotavirus vaccines in Taiwan, 2001\u20132013. Pediatr Infect Dis J. 2017. https:\/\/doi.org\/10.1097\/INF.0000000000001644.","journal-title":"Pediatr Infect Dis J"},{"key":"1141_CR33","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2017.0255","author":"J Koch","year":"2017","unstructured":"Koch J, Harder T, von Kries R, Wichmann O. Risk of intussusception after rotavirus vaccination. Dtsch Arztebl Int. 2017. https:\/\/doi.org\/10.3238\/arztebl.2017.0255.","journal-title":"Dtsch Arztebl Int"},{"key":"1141_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.05.064","author":"P Kassim","year":"2017","unstructured":"Kassim P, Eslick GD. Risk of intussusception following rotavirus vaccination: an evidence based meta-analysis of cohort and case-control studies. Vaccine. 2017. https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.064.","journal-title":"Vaccine"},{"key":"1141_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.10.014","author":"J Stowe","year":"2016","unstructured":"Stowe J, Andrews N, Ladhani S, Miller E. The risk of intussusception following monovalent rotavirus vaccination in England: a self-controlled case-series evaluation. Vaccine. 2016. https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.014.","journal-title":"Vaccine"},{"key":"1141_CR36","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-1082","author":"JE Tate","year":"2016","unstructured":"Tate JE, Yen C, Steiner CA, Cortese MM, Parashar UD. Intussusception rates before and after the introduction of rotavirus vaccine. Pediatrics. 2016. https:\/\/doi.org\/10.1542\/peds.2016-1082.","journal-title":"Pediatrics"},{"issue":"1","key":"1141_CR37","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1080\/21645515.2020.1770035","volume":"17","author":"V Vetter","year":"2021","unstructured":"Vetter V, Pereira P, Benninghoff B. Rotavirus vaccination and intussusception: a paradigm shift? Hum Vaccin Immunother. 2021;17(1):278\u201382. https:\/\/doi.org\/10.1080\/21645515.2020.1770035.","journal-title":"Hum Vaccin Immunother"},{"key":"1141_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-015-0376-7","author":"E Ledent","year":"2016","unstructured":"Ledent E, Lieftucht A, Buyse H, Sugiyama K, McKenna M, Holl K. Post-marketing benefit-risk assessment of rotavirus vaccination in Japan: a simulation and modelling analysis. Drug Saf. 2016. https:\/\/doi.org\/10.1007\/s40264-015-0376-7.","journal-title":"Drug Saf"},{"key":"1141_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/s2214-109x(19)30412-7","author":"A Clark","year":"2019","unstructured":"Clark A, Tate J, Parashar U, Jit M, Hasso-Agopsowicz M, Henschke N, et al. Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules. Lancet Glob Health. 2019. https:\/\/doi.org\/10.1016\/s2214-109x(19)30412-7.","journal-title":"Lancet Glob Health"},{"key":"1141_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa087","author":"H Arlegui","year":"2020","unstructured":"Arlegui H, Nachbaur G, Praet N, B\u00e9gaud B. Quantitative benefit-risk models used for rotavirus vaccination: a systematic review. Open Forum Infect Dis. 2020. https:\/\/doi.org\/10.1093\/ofid\/ofaa087.","journal-title":"Open Forum Infect Dis"},{"key":"1141_CR41","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2020.1800459","author":"P Pereira","year":"2020","unstructured":"Pereira P, Vetter V, Standaert B, Benninghoff B. Fifteen years of experience with the oral live-attenuated human rotavirus vaccine: reflections on lessons learned. Expert Rev Vaccines. 2020. https:\/\/doi.org\/10.1080\/14760584.2020.1800459.","journal-title":"Expert Rev Vaccines"},{"key":"1141_CR42","unstructured":"Medical Dictionary for Regulatory Activities Terminology (MedDRA). Version 23.0. http:\/\/www.meddra.org\/. Accessed 28 Jul 2020."},{"key":"1141_CR43","unstructured":"International Conference on Harmonisation. Topic E2A: Clinical safety data management: definitions and standards for expedited reporting. 1994. https:\/\/database.ich.org\/sites\/default\/files\/E2A_Guideline.pdf. Accessed 29 Nov 2021."},{"key":"1141_CR44","doi-asserted-by":"publisher","DOI":"10.1053\/spid.2002.125864","author":"NA Halsey","year":"2002","unstructured":"Halsey NA. The science of evaluation of adverse events associated with vaccination. Semin Pediatr Infect Dis. 2002. https:\/\/doi.org\/10.1053\/spid.2002.125864.","journal-title":"Semin Pediatr Infect Dis."},{"key":"1141_CR45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1107771","author":"S Escolano","year":"2011","unstructured":"Escolano S, Farrington CP, Hill C, Tubert-Bitter P. Intussusception after rotavirus vaccination\u2013spontaneous reports. N Engl J Med. 2011. https:\/\/doi.org\/10.1056\/NEJMc1107771.","journal-title":"N Engl J Med"},{"key":"1141_CR46","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.97","author":"IM Shui","year":"2012","unstructured":"Shui IM, Baggs J, Patel M, Parashar UD, Rett M, Belongia EA, et al. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA. 2012. https:\/\/doi.org\/10.1001\/jama.2012.97.","journal-title":"JAMA"},{"key":"1141_CR47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1311738","author":"ES Weintraub","year":"2014","unstructured":"Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, et al. Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med. 2014. https:\/\/doi.org\/10.1056\/NEJMoa1311738.","journal-title":"N Engl J Med"},{"key":"1141_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3918","author":"O Mahaux","year":"2016","unstructured":"Mahaux O, Bauchau V, Van Holle L. Pharmacoepidemiological considerations in observed-to-expected analyses for vaccines. Pharmacoepidemiol Drug Saf. 2016. https:\/\/doi.org\/10.1002\/pds.3918.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1141_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.06.084","author":"L Samad","year":"2013","unstructured":"Samad L, Cortina-Borja M, Bashir HE, Sutcliffe AG, Marven S, Cameron JC, et al. Intussusception incidence among infants in the UK and Republic of Ireland: a pre-rotavirus vaccine prospective surveillance study. Vaccine. 2013. https:\/\/doi.org\/10.1016\/j.vaccine.2013.06.084.","journal-title":"Vaccine"},{"key":"1141_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-12-36","author":"M Takeuchi","year":"2012","unstructured":"Takeuchi M, Osamura T, Yasunaga H, Horiguchi H, Hashimoto H, Matsuda S. Intussusception among Japanese children: an epidemiologic study using an administrative database. BMC Pediatr. 2012. https:\/\/doi.org\/10.1186\/1471-2431-12-36.","journal-title":"BMC Pediatr"},{"key":"1141_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230x-13-95","author":"X S\u00e1ez-Llorens","year":"2013","unstructured":"S\u00e1ez-Llorens X, Vel\u00e1zquez FR, Lopez P, Espinoza F, Linhares AC, Abate H, et al. A multi-country study of intussusception in children under 2 years of age in Latin America: analysis of prospective surveillance data. BMC Gastroenterol. 2013. https:\/\/doi.org\/10.1186\/1471-230x-13-95.","journal-title":"BMC Gastroenterol"},{"key":"1141_CR52","unstructured":"ClinicalTrials.gov. Study on the incidence of intussusception (IS) in children aged <\u00a012\u00a0months in Japan. 2012. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01479491. Accessed 29 Nov 2021."},{"key":"1141_CR53","unstructured":"GSK study register. Study on the incidence of intussusception (IS) in children aged <12 months in Japan. Available at: https:\/\/www.gsk-studyregister.com\/en\/trial-details\/?id=116259. Accessed 29 Nov 2021."},{"key":"1141_CR54","doi-asserted-by":"publisher","DOI":"10.1097\/inf.0b013e31824213b1","author":"PM Eng","year":"2012","unstructured":"Eng PM, Mast TC, Loughlin J, Clifford CR, Wong J, Seeger JD. Incidence of intussusception among infants in a large commercially insured population in the United States. Pediatr Infect Dis J. 2012. https:\/\/doi.org\/10.1097\/inf.0b013e31824213b1.","journal-title":"Pediatr Infect Dis J"},{"key":"1141_CR55","doi-asserted-by":"publisher","DOI":"10.1542\/peds.108.1.54","author":"HG Chang","year":"2001","unstructured":"Chang HG, Smith PF, Ackelsberg J, Morse DL, Glass RI. Intussusception, rotavirus diarrhea, and rotavirus vaccine use among children in New York state. Pediatrics. 2001. https:\/\/doi.org\/10.1542\/peds.108.1.54.","journal-title":"Pediatrics"},{"key":"1141_CR56","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/28.3-4.437","author":"F Garwood","year":"1936","unstructured":"Garwood F. (i) Fiducial limits for the Poisson distribution. Biometrika. 1936. https:\/\/doi.org\/10.1093\/biomet\/28.3-4.437.","journal-title":"Biometrika"},{"key":"1141_CR57","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-0035","author":"M Buettcher","year":"2007","unstructured":"Buettcher M, Baer G, Bonhoeffer J, Schaad UB, Heininger U. Three-year surveillance of intussusception in children in Switzerland. Pediatrics. 2007. https:\/\/doi.org\/10.1542\/peds.2007-0035.","journal-title":"Pediatrics"},{"key":"1141_CR58","doi-asserted-by":"publisher","DOI":"10.1542\/peds.106.6.1413","author":"UD Parashar","year":"2000","unstructured":"Parashar UD, Holman RC, Cummings KC, Staggs NW, Curns AT, Zimmerman CM, et al. Trends in intussusception-associated hospitalizations and deaths among US infants. Pediatrics. 2000. https:\/\/doi.org\/10.1542\/peds.106.6.1413.","journal-title":"Pediatrics"},{"key":"1141_CR59","doi-asserted-by":"publisher","DOI":"10.7883\/yoken.65.301","author":"A Noguchi","year":"2012","unstructured":"Noguchi A, Nakagomi T, Kimura S, Takahashi Y, Matsuno K, Koizumi H, et al. Incidence of intussusception as studied from a hospital-based retrospective survey over a 10-year period (2001\u20132010) in Akita Prefecture, Japan. Jpn J Infect Dis. 2012. https:\/\/doi.org\/10.7883\/yoken.65.301.","journal-title":"Jpn J Infect Dis"},{"key":"1141_CR60","unstructured":"World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2019 global summary. Immunization schedule for 1 disease (Rotavirus). 2020. http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/diseases. Accessed 19 Jan 2021."},{"key":"1141_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-70653-3","author":"G Bonaldo","year":"2020","unstructured":"Bonaldo G, Noseda R, Ceschi A, Vaccheri A, Motola D. Evaluation of the safety profile of rotavirus vaccines: a pharmacovigilance analysis on American and European data. Sci Rep. 2020. https:\/\/doi.org\/10.1038\/s41598-020-70653-3.","journal-title":"Sci Rep"},{"key":"1141_CR62","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2020.1775079","author":"BD Hallowell","year":"2020","unstructured":"Hallowell BD, Tate J, Parashar U. An overview of rotavirus vaccination programs in developing countries. Expert Rev Vaccines. 2020. https:\/\/doi.org\/10.1080\/14760584.2020.1775079.","journal-title":"Expert Rev Vaccines"},{"key":"1141_CR63","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix369","author":"CL Jonesteller","year":"2017","unstructured":"Jonesteller CL, Burnett E, Yen C, Tate JE, Parashar UD. Effectiveness of rotavirus vaccination: a systematic review of the first decade of global postlicensure data, 2006\u20132016. Clin Infect Dis. 2017. https:\/\/doi.org\/10.1093\/cid\/cix369.","journal-title":"Clin Infect Dis"},{"key":"1141_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.11.026","author":"P Haber","year":"2021","unstructured":"Haber P, Tate J, Marquez PL, Moro PL, Parashar U. Safety profile of rotavirus vaccines among individuals aged \u22658months of age, United States, vaccine adverse event reporting system (VAERS), 2006\u20132019. Vaccine. 2021. https:\/\/doi.org\/10.1016\/j.vaccine.2020.11.026.","journal-title":"Vaccine"},{"key":"1141_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.03.007","author":"N Aliabadi","year":"2016","unstructured":"Aliabadi N, Tate JE, Parashar UD. Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines. Clin Microbiol Infect. 2016. https:\/\/doi.org\/10.1016\/j.cmi.2016.03.007.","journal-title":"Clin Microbiol Infect"},{"key":"1141_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30244-X","author":"M O'Ryan","year":"2017","unstructured":"O\u2019Ryan M, Lopman BA. Parenteral protein-based rotavirus vaccine. Lancet Infect Dis. 2017. https:\/\/doi.org\/10.1016\/S1473-3099(17)30244-X.","journal-title":"Lancet Infect Dis"},{"key":"1141_CR67","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piz035","author":"RM Burke","year":"2020","unstructured":"Burke RM, Tate JE, Dahl RM, Aliabadi N, Parashar UD. Does rotavirus vaccination affect longer-term intussusception risk in US infants? J Pediatric Infect Dis Soc. 2020. https:\/\/doi.org\/10.1093\/jpids\/piz035.","journal-title":"J Pediatric Infect Dis Soc."},{"key":"1141_CR68","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1029212","author":"B Standaert","year":"2015","unstructured":"Standaert B, Alwan A, Strens D, Raes M, Postma MJ. Improvement in hospital Quality of Care (QoC) after the introduction of rotavirus vaccination: An evaluation study in Belgium. Hum Vaccin Immunother. 2015. https:\/\/doi.org\/10.1080\/21645515.2015.1029212.","journal-title":"Hum Vaccin Immunother"},{"key":"1141_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/s1055-8586(99)70029-6","author":"JW DiFiore","year":"1999","unstructured":"DiFiore JW. Intussusception. Semin Pediatr Surg. 1999. https:\/\/doi.org\/10.1016\/s1055-8586(99)70029-6.","journal-title":"Semin Pediatr Surg"},{"key":"1141_CR70","doi-asserted-by":"publisher","DOI":"10.4103\/0189-6725.194665","author":"OO Ogundoyin","year":"2016","unstructured":"Ogundoyin OO, Olulana DI, Lawal TA. Childhood intussusception: Impact of delay in presentation in a developing country. Afr J Paediatr Surg. 2016. https:\/\/doi.org\/10.4103\/0189-6725.194665.","journal-title":"Afr J Paediatr Surg"},{"key":"1141_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/s0149-2918(98)80007-6","author":"SA Goldman","year":"1998","unstructured":"Goldman SA. Limitations and strengths of spontaneous reports data. Clin Ther. 1998. https:\/\/doi.org\/10.1016\/s0149-2918(98)80007-6.","journal-title":"Clin Ther"}],"updated-by":[{"DOI":"10.1007\/s40264-022-01167-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000}}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-021-01141-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-021-01141-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-021-01141-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T09:38:44Z","timestamp":1648201124000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-021-01141-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1141"],"URL":"https:\/\/doi.org\/10.1007\/s40264-021-01141-4","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"assertion":[{"value":"13 December 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40264-022-01167-2","URL":"https:\/\/doi.org\/10.1007\/s40264-022-01167-2","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was supported by GlaxoSmithKline Biologicals SA, which was the funding source and was involved in all stages of the study conduct and analysis. GlaxoSmithKline Biologicals SA also took responsibility for all costs associated with the development and publishing of the present manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Tina Singh, Fr\u00e9d\u00e9rique Delannois, Fran\u00e7ois Haguinet, and Lifeter Yenwo Molo are employees of the GSK group of companies. Fr\u00e9d\u00e9rique Delannois, Fran\u00e7ois Haguinet, and Tina Singh hold shares in the GSK group of companies as part of their employee remuneration. The authors declare no other financial or non-financial conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Rotarix is a trademark owned by the GSK group of companies; RotaTeq is a registered trademark of Merck & Co., Inc.; Rotavac is a registered trademark of Bharat Biotech; and Rotasiil is a registered trademark of the Serum Institute of India Ltd.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Trademark statements"}},{"value":"The data that support the findings of this work are available from the corresponding author on reasonable request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors participated in the design, implementation, analysis and interpretation of the study, as well as the development of this manuscript. All authors had full access to the data and granted their final approval of the paper before submission.","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}